Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
2.590
+0.035 (1.37%)
At close: Sep 4, 2026, 4:00 PM EDT
2.580
-0.010 (-0.39%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Compugen Revenue

Compugen had revenue of $2.60M in the quarter ending June 30, 2026, with 107.00% growth. This brings the company's revenue in the last twelve months to $74.00M, up 234.18% year-over-year. In the year 2025, Compugen had annual revenue of $72.76M with 161.14% growth.

Revenue (ttm)
$74.00M
Revenue Growth
+234.18%
P/S Ratio
3.32
Revenue / Employee
$986,680
Employees
75
Market Cap
245.34M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202572.76M44.90M161.14%
Dec 31, 202427.86M-5.60M-16.72%
Dec 31, 202333.46M25.96M346.12%
Dec 31, 20227.50M1.50M25.00%
Dec 31, 20216.00M4.00M200.00%
Dec 31, 20202.00M--
Dec 31, 2019---
Dec 31, 201817.80M--
Dec 31, 2017---
Dec 31, 2016712.00K-8.57M-92.33%
Dec 31, 20159.28M-3.09M-24.99%
Dec 31, 201412.37M8.82M248.46%
Dec 31, 20133.55M3.31M1,366.53%
Dec 31, 2012242.00K--
Dec 31, 2011---
Dec 31, 20101.12M865.00K346.00%
Dec 31, 2009250.00K-88.00K-26.04%
Dec 31, 2008338.00K158.00K87.78%
Dec 31, 2007180.00K-35.00K-16.28%
Dec 31, 2006215.00K-431.00K-66.72%
Dec 31, 2005646.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Niagen Bioscience129.08M
Cellectis63.82M
Invivyd58.37M
Atrium Therapeutics35.84M
Adagene9.29M
Entrada Therapeutics4.69M
Camp4 Therapeutics4.22M
YD Bio510.36K
Revenue Rankings